RUNX2 and cancer: Our data indicate that RUNX2 – through its widespread transcriptional activity – is a key factor for a balanced gene expression that fosters cancer cell fitness through the downregulation of mitochondrial respiration and the promotion of anabolic pathways like de novo lipogenesis.